Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT05061719
Lumateperone for depression
This study is completed in the United States, in Bulgaria, in Czechia, .... It is testing lumateperone for depression.
DepressionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: October 8, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 812
- Sponsor
- Intra-Cellular Therapies, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Bulgaria, Czechia, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05061719
- Official title
- An Open-label, Multicenter Trial to Assess the Safety and Tolerability of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05061719. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Bulgaria · 13 sites
- Clinical SiteBurgasSite status: Not listed — confirm with the team
- Clinical SiteKazanlakSite status: Not listed — confirm with the team
- Clinical SiteNovi IskarSite status: Not listed — confirm with the team
- Clinical SitePlevenSite status: Not listed — confirm with the team
- Clinical SitePlovdivSite status: Not listed — confirm with the team
- Clinical SiteRousseSite status: Not listed — confirm with the team
- Clinical SiteSofiaSite status: Not listed — confirm with the team
- Clinical SiteSofiaSite status: Not listed — confirm with the team
- Clinical SiteTargovishteSite status: Not listed — confirm with the team
- Clinical SiteTsarev BrodSite status: Not listed — confirm with the team
- Clinical SiteVeliko TarnovoSite status: Not listed — confirm with the team
- Clinical SiteVeliko TarnovoSite status: Not listed — confirm with the team
- Clinical SiteVratsaSite status: Not listed — confirm with the team
Czechia · 8 sites
- Clinical SiteBrnoSite status: Not listed — confirm with the team
- Clinical siteBrnoSite status: Not listed — confirm with the team
- Clinical SiteHostiviceSite status: Not listed — confirm with the team
- Clinical SiteOstravaSite status: Not listed — confirm with the team
- Clinical SitePilsenSite status: Not listed — confirm with the team
- Clinical SitePragueSite status: Not listed — confirm with the team
- Clinical SitePragueSite status: Not listed — confirm with the team
- Clinical SitePragueSite status: Not listed — confirm with the team
Finland · 2 sites
- Clinical SiteHelsinkiSite status: Not listed — confirm with the team
- Clinical SiteOuluSite status: Not listed — confirm with the team
Germany · 6 sites
- Clinical SiteBad HomburgSite status: Not listed — confirm with the team
- Clinical SiteFreiburg im BreisgauSite status: Not listed — confirm with the team
- Clinical SiteHamburgSite status: Not listed — confirm with the team
- Clinical SiteMittweidaSite status: Not listed — confirm with the team
- Clinical SiteSchwerinSite status: Not listed — confirm with the team
- Clinical SiteWesterstedeSite status: Not listed — confirm with the team
Hungary · 6 sites
- Clinical SiteBudapestSite status: Not listed — confirm with the team
- Clinical SiteBudapestSite status: Not listed — confirm with the team
- Clinical SiteBudapestSite status: Not listed — confirm with the team
- Clinical SiteBudapestSite status: Not listed — confirm with the team
- Clinical SiteDebrecenSite status: Not listed — confirm with the team
- Clinical SiteGyöngyösSite status: Not listed — confirm with the team
India · 10 sites
- Clinical SiteGuwahati, AssamSite status: Not listed — confirm with the team
- Clinical SiteAhmedabad, GujaratSite status: Not listed — confirm with the team
- Clinical SiteJūnāgadh, GujaratSite status: Not listed — confirm with the team
- Clinical SiteVadodara, GujaratSite status: Not listed — confirm with the team
- Clinical SiteMysore, KarnatakaSite status: Not listed — confirm with the team
- Clinical SiteAurangabad, MaharashtraSite status: Not listed — confirm with the team
- Clinical SiteNagpur, MaharashtraSite status: Not listed — confirm with the team
- Clinical SiteNashik, MaharashtraSite status: Not listed — confirm with the team
- Clinical SiteMumbaiSite status: Not listed — confirm with the team
- Clinical SiteNashikSite status: Not listed — confirm with the team
Poland · 11 sites
- Clinical SiteBełchatówSite status: Not listed — confirm with the team
- Clinical SiteBialystokSite status: Not listed — confirm with the team
- Clinical SiteBialystokSite status: Not listed — confirm with the team
- Clinical SiteBialystokSite status: Not listed — confirm with the team
- Clinical SiteBydgoszczSite status: Not listed — confirm with the team
- Clinical SiteGdanskSite status: Not listed — confirm with the team
- Clinical SiteGorliceSite status: Not listed — confirm with the team
- Clinical SiteLesznoSite status: Not listed — confirm with the team
- Clinical SitePruszcz GdańskiSite status: Not listed — confirm with the team
- Clinical SIteTorunSite status: Not listed — confirm with the team
- Clinical SiteWroclawSite status: Not listed — confirm with the team
Slovakia · 6 sites
- Clinical SiteBratislavaSite status: Not listed — confirm with the team
- Clinical SiteKošiceSite status: Not listed — confirm with the team
- Clinical SiteRimavská SobotaSite status: Not listed — confirm with the team
- Clinical SiteSvidníkSite status: Not listed — confirm with the team
- Clinical SiteVranov nad TopľouSite status: Not listed — confirm with the team
- Clinical SiteZlaté MoravceSite status: Not listed — confirm with the team
South Korea · 5 sites
- Clinical SiteAnsan-si, North ChungcheongSite status: Not listed — confirm with the team
- Clinical SiteGwangjuSite status: Not listed — confirm with the team
- Clinical SiteSeoulSite status: Not listed — confirm with the team
- Clinical SiteSeoulSite status: Not listed — confirm with the team
- Clinical SiteSeoulSite status: Not listed — confirm with the team
Sweden · 2 sites
- Clinical SiteLundSite status: Not listed — confirm with the team
- Clinical SiteStockholmSite status: Not listed — confirm with the team
United States · 40 sites
- Clinical SitePhoenix, ArizonaSite status: Not listed — confirm with the team
- Clinical SiteBentonville, ArkansasSite status: Not listed — confirm with the team
- Clinical SiteLittle Rock, ArkansasSite status: Not listed — confirm with the team
- Clinical SiteRogers, ArkansasSite status: Not listed — confirm with the team
- Clinical SiteCulver City, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteGlendale, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteNewport Beach, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteOceanside, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteRedlands, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteRiverside, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteSan Diego, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteSherman Oaks, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteTemecula, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteUpland, CaliforniaSite status: Not listed — confirm with the team
- Clinical SiteFort Lauderdale, FloridaSite status: Not listed — confirm with the team
- Clinical SiteJacksonville, FloridaSite status: Not listed — confirm with the team
- Clinical SiteOrlando, FloridaSite status: Not listed — confirm with the team
- Clinical SitePalm Bay, FloridaSite status: Not listed — confirm with the team
- Clinical SiteWest Palm Beach, FloridaSite status: Not listed — confirm with the team
- Clinical SiteAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Clinical SiteAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Clinical SiteAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Clinical SiteDecatur, GeorgiaSite status: Not listed — confirm with the team
- Clinical SiteJoliet, IllinoisSite status: Not listed — confirm with the team
- Clinical SiteOverland Park, KansasSite status: Not listed — confirm with the team
- Clinical SiteGaithersburg, MarylandSite status: Not listed — confirm with the team
- Clinical SiteBoston, MassachusettsSite status: Not listed — confirm with the team
- Clinical SiteFlowood, MississippiSite status: Not listed — confirm with the team
- Clinical SiteSaint Charles, MissouriSite status: Not listed — confirm with the team
- Clinical SiteBerlin, New JerseySite status: Not listed — confirm with the team
- Clinical SiteToms River, New JerseySite status: Not listed — confirm with the team
- Clinical SiteBrooklyn, New YorkSite status: Not listed — confirm with the team
- Clinical SiteCedarhurst, New YorkSite status: Not listed — confirm with the team
- Clinical SiteMount Kisco, New YorkSite status: Not listed — confirm with the team
- Clinical SiteCharlotte, North CarolinaSite status: Not listed — confirm with the team
- Clinical SiteAllentown, PennsylvaniaSite status: Not listed — confirm with the team
- Clinical SiteMedia, PennsylvaniaSite status: Not listed — confirm with the team
- Clinical SitePlymouth Meeting, PennsylvaniaSite status: Not listed — confirm with the team
- Clinical SiteAustin, TexasSite status: Not listed — confirm with the team
- Clinical SiteBellevue, WashingtonSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Lumateperone. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Intra-Cellular Therapies, Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.
CompletedNCT03902613
18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.